Study of SkQ1 as Treatment for Dry-eye Syndrome

Completed · Phase 3 · Has a placebo group

Conditions studied: Dry Eye Syndrome

In brief

The purpose of this study is to evaluate whether SkQ1 ophthalmic solutions are safe and effective compared to placebo for the treatment of the signs and symptoms of dry eye syndrome.

Key facts

Study ID
NCT03764735
Run by
Mitotech, SA
People needed
452
Starts
2018-12-06
Expected to finish
2019-02-09
Last updated by the study team
2022-01-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.